MC-PC-12004/MRC_/Medical Research Council/United Kingdom[Grants and Funding] - Search Results

Year	Number of Results
1976	1
2012	1
2013	2
2014	3
2015	3
2016	9
2017	12
2018	11
2019	7
2020	6
2021	2
2022	2
2024	0

1

Oxidative Phosphorylation as an Emerging Target in Cancer Therapy.

Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS. Ashton TM, et al. Clin Cancer Res. 2018 Jun 1;24(11):2482-2490. doi: 10.1158/1078-0432.CCR-17-3070. Epub 2018 Feb 2. Clin Cancer Res. 2018. PMID: 29420223 Review.

2

Subcellular Targeting of Theranostic Radionuclides.

Bavelaar BM, Lee BQ, Gill MR, Falzone N, Vallis KA. Bavelaar BM, et al. Front Pharmacol. 2018 Sep 4;9:996. doi: 10.3389/fphar.2018.00996. eCollection 2018. Front Pharmacol. 2018. PMID: 30233374 Free PMC article. Review.

3

Targeted radionuclide therapy in combined-modality regimens.

Gill MR, Falzone N, Du Y, Vallis KA. Gill MR, et al. Lancet Oncol. 2017 Jul;18(7):e414-e423. doi: 10.1016/S1470-2045(17)30379-0. Lancet Oncol. 2017. PMID: 28677577 Review.

4

Targeting ATR in DNA damage response and cancer therapeutics.

Fokas E, Prevo R, Hammond EM, Brunner TB, McKenna WG, Muschel RJ. Fokas E, et al. Cancer Treat Rev. 2014 Feb;40(1):109-17. doi: 10.1016/j.ctrv.2013.03.002. Epub 2013 Apr 11. Cancer Treat Rev. 2014. PMID: 23583268 Review.

5

Targeting telomerase with radiolabeled inhibitors.

Waghorn PA, Jackson MR, Gouverneur V, Vallis KA. Waghorn PA, et al. Eur J Med Chem. 2017 Jan 5;125:117-129. doi: 10.1016/j.ejmech.2016.09.028. Epub 2016 Sep 10. Eur J Med Chem. 2017. PMID: 27657809 Free PMC article.

6

Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases.

Falzone N, Ackerman NL, Rosales LF, Bernal MA, Liu X, Peeters SG, Soto MS, Corroyer-Dulmont A, Bernaudin M, Grimoin E, Touzani O, Sibson NR, Vallis KA. Falzone N, et al. Theranostics. 2018 Jan 1;8(1):292-303. doi: 10.7150/thno.22217. eCollection 2018. Theranostics. 2018. PMID: 29290808 Free PMC article.

7

Depletion of signal recognition particle 72kDa increases radiosensitivity.

Prevo R, Tiwana GS, Maughan TS, Buffa FM, McKenna WG, Higgins GS. Prevo R, et al. Cancer Biol Ther. 2017 Jun 3;18(6):425-432. doi: 10.1080/15384047.2017.1323587. Epub 2017 May 11. Cancer Biol Ther. 2017. PMID: 28494188 Free PMC article.

8

Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic.

Fokas E, O'Neill E, Gordon-Weeks A, Mukherjee S, McKenna WG, Muschel RJ. Fokas E, et al. Biochim Biophys Acta. 2015 Jan;1855(1):61-82. doi: 10.1016/j.bbcan.2014.12.001. Epub 2014 Dec 7. Biochim Biophys Acta. 2015. PMID: 25489989 Review.

9

Track to the future: historical perspective on the importance of radiation track structure and DNA as a radiobiological target.

Hill MA. Hill MA. Int J Radiat Biol. 2018 Aug;94(8):759-768. doi: 10.1080/09553002.2017.1387304. Epub 2017 Dec 8. Int J Radiat Biol. 2018. PMID: 29219655 Free PMC article. Review.

10

Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells.

Tietz O, Cortezon-Tamarit F, Chalk R, Able S, Vallis KA. Tietz O, et al. Nat Chem. 2022 Mar;14(3):284-293. doi: 10.1038/s41557-021-00866-0. Epub 2022 Feb 10. Nat Chem. 2022. PMID: 35145246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

53 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year